Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.
Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.
Anal Chim Acta. 2019 Apr 4;1052:37-48. doi: 10.1016/j.aca.2018.12.009. Epub 2018 Dec 15.
Over the last four decades, there has been a pursuit for a non-invasive solution for glucose measurement, but there is not yet any viable product released. Of the many sensor modalities tried, the combination of electrical and optical measurement is among the most promising for continuous measurements. Although non-invasive prediction of exact glucose levels may seem futile, prediction of their trends may be useful for certain applications. Hypoglycemia is the most serious of the acute complications in type-1 diabetes highlighting the need for a reliable alarm, but little is known about the performance of this technology in predicting hypoglycemic glucose levels and associated trends. We aimed to assess such performance on the way to develop a multisensor system for detection of hypoglycemia, based on near-infrared (NIR), bioimpedance and skin temperature measurements taken during hypoglycemic and euglycemic glucose clamps in 20 subjects with type-1 diabetes. Performance of blood glucose prediction was assessed by global partial least squares and neural network regression models using repeated double cross-validation. Best trend prediction was obtained by including all measurements in a neural network model. Prediction of glucose level was inaccurate for threshold-based detection of hypoglycemia, but the trend predictions may provide useful information in a multisensor system. Comparing NIR and bioimpedance measurements, NIR seems to be the main predictor of blood glucose while bioimpedance may act as correction for individual confounding properties.
在过去的四十年中,人们一直在寻求一种非侵入性的葡萄糖测量解决方案,但目前仍没有任何可行的产品问世。在尝试的众多传感器模式中,电和光测量的组合是最有前途的连续测量方法之一。虽然非侵入性地预测确切的血糖水平似乎不太可能,但预测其趋势对于某些应用可能是有用的。低血糖是 1 型糖尿病最严重的急性并发症之一,突出了对可靠警报的需求,但对于这项技术在预测低血糖血糖水平和相关趋势方面的性能知之甚少。我们旨在评估这种性能,以开发一种基于近红外(NIR)、生物阻抗和皮肤温度测量的多传感器系统,用于检测低血糖,该系统基于 20 名 1 型糖尿病患者在低血糖和正常血糖钳夹期间的测量。使用重复双交叉验证,通过全局偏最小二乘和神经网络回归模型评估血糖预测性能。通过在神经网络模型中包含所有测量值,可以获得最佳的趋势预测。基于阈值的低血糖检测的血糖水平预测不准确,但趋势预测在多传感器系统中可能提供有用的信息。比较 NIR 和生物阻抗测量值,NIR 似乎是血糖的主要预测因子,而生物阻抗可能是个体混杂特性的校正因子。